Therapeutic Solutions International Announces Positive Clinical Data Using NanoStilbene™ to Stimulate Immune System in Advanced Cancer Patients
August 26, 2019 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today positive results from a pilot clinical trial...
Grey Wolf Therapeutics completes £10 million ($14 million) series A financing with Andera Partners and Canaan to fund development of immuno-oncology therapies to increase tumour visibility
February 11, 2019 01:00 ET
|
Grey Wolf Therapeutics
Grey Wolf Therapeutics completes £10 million ($14 million) series A financing with Andera Partners and Canaan to fund development of immuno-oncology therapies to increase tumour visibility Grey Wolf...
Trivedi Global, Inc. and Jagdish Singh Announce Research Results of Biofield Energy Treated Nutraceutical Formulated to Enhance Immunity and Combat Inflammatory and Autoimmune Disorders
May 30, 2018 13:30 ET
|
Trivedi Global, Inc.
Cleveland, Ohio, May 30, 2018 (GLOBE NEWSWIRE) -- Jagdish Singh, an energy healer with scientific validation, today announces the impact of a biofield energy treated proprietary supplement to...
Immudyne Announces Launch of INR Wellness Immune Support Product Line
March 19, 2018 09:01 ET
|
ImmuDyne, Inc.
NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) (“Immudyne” or the “Company”), a leader in the development and marketing of OTC healthcare products, is pleased to announce...
PreveCeutical™ Medical Inc. Begins Trading on the Frankfurt Stock Exchange
August 01, 2017 08:30 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 01, 2017 (GLOBE NEWSWIRE) -- PreveCeutical™ Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces the listing of its common shares for trading on the...
Commence Bio to Present at 2016 Cell & Gene Meeting on the Mesa
September 28, 2016 12:37 ET
|
Commence Bio
SPARKS, MD--(Marketwired - September 28, 2016) - Commence Bio, Inc., a biotechnology company focused on developing breakthrough immunotherapies using its proprietary STaRT™ platform, announced today...
Stellar Biotechnologies Awarded $498,560 Phase IIB National Science Foundation (NSF) Grant
August 29, 2011 16:05 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Aug 29, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that the National Science Foundation (NSF) has...
Stellar Biotechnologies Announces Pre-IDE Meeting With FDA
May 10, 2011 09:45 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - May 10, 2011) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) announces the completion of a pre-Investigational Device Exemption (pre-IDE) meeting...
Stellar Biotechnologies Appoints Vice President, Business Development & Marketing
March 08, 2011 08:55 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - March 8, 2011) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) has appointed Michael R. McClurg to VP, Business Development & Marketing. His...
What Is Attacking Our Immune System and How Can We Stop It?
March 04, 2010 13:51 ET
|
Dr. Sherrill Sellman
BROOKINGS, SD--(Marketwire - March 4, 2010) - Poor diet and lack of sleep can make us feel fatigued and run-down, but what most people don't know is how basic stressors can tax our immune...